Hanson Pharmaceuticals (002412.SZ) released its report for the third quarter of 2024. In the first three quarters, the company achieved operating revenue...
According to the Zhitong Finance App, Hanson Pharmaceuticals (002412.SZ) released its report for the third quarter of 2024. In the first three quarters, the company achieved revenue of 0.694 billion yuan, an increase of 1.44% over the previous year. Net profit attributable to shareholders of listed companies was 0.131 billion yuan, a year-on-year increase of 19.15%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 0.123 billion yuan, an increase of 19.14% over the previous year.